|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 74.49 USD | +0.17% |
|
-0.41% | +25.87% |
| 07-16 | Ingevity Receives BASt Approval For Evotherm P35 Warm-Mix Additive In Germany | CI |
| 06-25 | Ingevity Names Ryan Cotterman as Chief Accounting Officer | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 89 | +19.48% | 3 | ||||||
| 8,068.82 | +37.41% | 17 | ||||||
| 52.26 | +6.73% | 21 | ||||||
| 1,652.9 | +2.06% | 21 | ||||||
| 1,944.17 | +7% | 12 | ||||||
| 1,189.09 | +2.07% | 11 | ||||||
| 56.57 | -6.83% | 14 | ||||||
| 71.76 | +0.3% | 17 | ||||||
| 2,933.27 | +11.26% | 30 | ||||||
| 203.11 | +7.65% | 9 | ||||||
| 8,311.11 | +12.02% | 9 | ||||||
| - | - | 39 | +14.04% | 1 | ||||
| 23.61 | +14.94% | 16 | ||||||
| 663.33 | +25.2% | 9 | ||||||
| 3,092.22 | +12.65% | 9 | ||||||
| 25.01 | -5.32% | 15 | ||||||
| 71.27 | +4.8% | 11 | ||||||
| 184.5 | +29% | 4 | ||||||
| 18.95 | +12.2% | 6 | ||||||
| Average | 1,510 | +10.88% | 12 | ||||||
| Weighted average by Cap. | 3,037.83 | +15.75% | 16 |
- Stock Market
- Stocks
- NGVT Stock
- Sector Ingevity Corporation
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
